analyst forecasts

Netflix (NFLX) Stock Today: Post‑Split Price, Q3 2025 Earnings Shock, Analyst Targets and the Ad‑Tier Boom

Date: November 30, 2025 As investors head into the final stretch of 2025, Netflix, Inc. (NASDAQ: NFLX) sits at the center of three big storylines: a fresh 10‑for‑1 stock split, a noisy third‑quarter earnings miss tied to a Brazil tax

30 November 2025

Germany’s Submarine Builder TKMS Debuts Amid Defense Boom – Is It the Next Rheinmetall?

TKMS Stock Skyrockets in Debut, Doubling Analyst Forecasts Amid Defense Boom

Frankfurt, Oct. 20, 2025 – Shares of Thyssenkrupp Marine Systems (TKMS) – the warship-building arm of Thyssenkrupp – made a splashy entrance on the Frankfurt Stock Exchange today. The newly listed stock surged far above initial expectations as investors clamored

20 October 2025

Defense Industry · Economic Trends · Financial Analysis · Investment News · Stock Market

Chevron (CVX) Stock: Oil Price Doldrums, Pipeline Deal & Analysts’ Forecasts – What’s Next?

Current Stock Performance Chevron’s stock (NYSE: CVX) has been relatively flat in recent days. After closing around $152–153 last week investing.com, CVX closed at $153.08 on Oct 17 (up ~0.9% that day) investing.com. This puts it roughly in the middle

18 October 2025

Energy Sector · Investment Insights · Market Trends · NYSE:CVX · Oil Industry · Stock Analysis

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Financial Group’s logo displayed on the trading floor of the New York Stock Exchange. The stock has seesawed amid strong earnings and fallout from a client’s bankruptcy. reuters.com tradingview.com Earnings Soar on Dealmaking Rebound Jefferies’ latest quarterly report showcased

16 October 2025

Analyst Insights · Earnings Reports · Financial News · Investment Strategies · NYSE:JEF · Stock Market

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

Company Background AstraZeneca PLC is a leading Anglo-Swedish pharmaceutical giant specializing in oncology, respiratory, cardiovascular/metabolic, and rare disease medicines marketbeat.com astrazeneca.com. Headquartered in Cambridge, UK, it maintains primary listings on the London Stock Exchange and Nasdaq Stockholm, with secondary ADR

11 October 2025

Analyst Insights · Business News · Investment · Pharmaceuticals · Stock Market

Robinhood (HOOD) Skyrockets: S&P 500 Entry, Explosive Q2 Results & Bullish Analyst Forecasts

In summary, as of Sep 29, 2025 Robinhood (HOOD) is enjoying a major rally underpinned by strong earnings, big user growth, and high-profile expansions (S&P 500 entry, crypto deals, new products). Analysts generally expect continued growth (average targets in the

29 September 2025

Analyst Insights · Earnings Reports · Financial News · Investing · NASDAQ:HOOD · Stock Market